CytomX Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $358.7M
Liabilities Breakdown FY2020
Total Liabilities: $366.4M
Asset Breakdown
Total Assets: $358.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $191.9M | 53.5% |
| Accounts Receivable | $798.0K | 0.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $7.0M | 1.9% |
| Goodwill | $949.0K | 0.3% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $158.1M | 44.1% |
Liabilities Breakdown
Total Liabilities: $366.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.0M | 0.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $363.4M | 99.2% |